Provided by Tiger Fintech (Singapore) Pte. Ltd.

Talaris Therapeutics Inc.

12.08
0.0000
Volume:- -
Turnover:837.55K
Market Cap:5.17M
PE:-0.67
High:12.08
Open:12.08
Low:12.08
Close:12.08
Loading ...

Talaris Thera (NASDAQ: TALS) stock to jump 1,000% then fall $15 ...

Dhaka Tribune
·
20 Oct 2023

Press Release: Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million

Dow Jones
·
20 Oct 2023

BUZZ-Talaris Therapeutics up on Tourmaline Bio deal, reverse stock split approval

Reuters
·
18 Oct 2023

BRIEF-Talaris Therapeutics Announces Stockholder Approval Of Merger With Tourmaline Bio

Reuters
·
18 Oct 2023

Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio

GlobeNewswire
·
17 Oct 2023

TALS Dividend Announcement $1.5118/Share 10/9/2023

Dividend Investor
·
10 Oct 2023

Stocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed Martin

Dow Jones
·
07 Oct 2023

Shares of Talaris Therapeutics Climb 5.2% on Special Dividend Tied to Merger

Dow Jones
·
07 Oct 2023

Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio

GlobeNewswire
·
06 Oct 2023

BRIEF-New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development And Manufacturing Facilities From Talaris Therapeutics

Reuters
·
04 Oct 2023

New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics

GlobeNewswire
·
04 Oct 2023

Press Release: ImmunoFree Inc. has Acquired Talaris Therapeutics, Inc.'s Tolerance Business

Dow Jones
·
15 Aug 2023

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasda

StreetInsider
·
29 Jul 2023

Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

StreetInsider
·
22 Jun 2023

Talaris Shares Jump on Merger Deal With Tourmaline

Dow Jones
·
22 Jun 2023